Giuseppe
Emeritus
[Source: US National Library of Medicine (LINK). Edited.]
J Virol. 2010 May 5. [Epub ahead of print]
Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein.
Hale BG, Steel J, Medina RA, Manicassamy B, Ye J, Hickman D, Hai R, Schmolke M, Lowen AC, Perez DR, Garc?a-Sastre A. - Department of Microbiology, Department of Medicine, Division of Infectious Diseases, Global Health and Emerging Pathogens Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA; Department of Veterinary Medicine, University of Maryland, College Park, MD 20742, USA.
In 2009, a novel swine-origin H1N1 influenza A virus emerged. Here, we characterize the multifunctional NS1 protein of this human pandemic virus in order to understand factors that may contribute towards replication efficiency or pathogenicity. Although the 2009 H1N1 virus NS1 protein (2009/NS1) is an effective interferon-antagonist, we found that this NS1 (unlike those of previous human-adapted influenza A viruses) is unable to block general host gene expression in human or swine cells. This property could be restored in 2009/NS1 by substituting R108, E125 and G189 for residues corresponding to human virus consensus. Mechanistically, these previously undescribed mutations acted by increasing binding of 2009/NS1 to the cellular pre-mRNA processing protein CPSF30. A recombinant 2009 H1N1 influenza A virus (A/California/04/09) expressing NS1 with these gain-of-function substitutions was more efficient than wild-type at antagonizing host innate immune responses in primary human epithelial cells. However, such mutations had no significant effect on virus replication in either human or swine tissue-culture substrates. Surprisingly, in a mouse model of pathogenicity, the mutant virus appeared to cause less morbidity, and was cleared faster, than wild-type. The mutant virus also demonstrated reduced titers in the upper respiratory tracts of ferrets, however contact and aerosol transmissibility of the virus were unaffected. Our data highlight a potential human adaptation of NS1 that seems absent in 'classically-derived' swine-origin influenza A viruses, including the 2009 H1N1 virus. We discuss the impact that natural future gain of this NS1 function may have on the new pandemic virus in humans.
PMID: 20444891 [PubMed - as supplied by publisher]
-
-----
J Virol. 2010 May 5. [Epub ahead of print]
Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein.
Hale BG, Steel J, Medina RA, Manicassamy B, Ye J, Hickman D, Hai R, Schmolke M, Lowen AC, Perez DR, Garc?a-Sastre A. - Department of Microbiology, Department of Medicine, Division of Infectious Diseases, Global Health and Emerging Pathogens Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA; Department of Veterinary Medicine, University of Maryland, College Park, MD 20742, USA.
In 2009, a novel swine-origin H1N1 influenza A virus emerged. Here, we characterize the multifunctional NS1 protein of this human pandemic virus in order to understand factors that may contribute towards replication efficiency or pathogenicity. Although the 2009 H1N1 virus NS1 protein (2009/NS1) is an effective interferon-antagonist, we found that this NS1 (unlike those of previous human-adapted influenza A viruses) is unable to block general host gene expression in human or swine cells. This property could be restored in 2009/NS1 by substituting R108, E125 and G189 for residues corresponding to human virus consensus. Mechanistically, these previously undescribed mutations acted by increasing binding of 2009/NS1 to the cellular pre-mRNA processing protein CPSF30. A recombinant 2009 H1N1 influenza A virus (A/California/04/09) expressing NS1 with these gain-of-function substitutions was more efficient than wild-type at antagonizing host innate immune responses in primary human epithelial cells. However, such mutations had no significant effect on virus replication in either human or swine tissue-culture substrates. Surprisingly, in a mouse model of pathogenicity, the mutant virus appeared to cause less morbidity, and was cleared faster, than wild-type. The mutant virus also demonstrated reduced titers in the upper respiratory tracts of ferrets, however contact and aerosol transmissibility of the virus were unaffected. Our data highlight a potential human adaptation of NS1 that seems absent in 'classically-derived' swine-origin influenza A viruses, including the 2009 H1N1 virus. We discuss the impact that natural future gain of this NS1 function may have on the new pandemic virus in humans.
PMID: 20444891 [PubMed - as supplied by publisher]
-
-----